IP Library Granted Patent US 10,737,024
Granted Patent B2
US 10,737,024 · App. 15/047,028 · Granted Aug 11, 2020

Fluid delivery and infusion devices, and methods of use thereof

Inventor: Kevin G. Schmid (Boxford, MA)
Assignee: INSULET CORPORATION
A61M5/1723A61M5/14248A61M2005/1402A61M2005/14208A61M2005/14252A61M2005/1585A61M2005/1726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,737,024
App. No.
15/047,028
Granted
Aug 11, 2020
Kind
B2
Abstract

A medical device comprising an infusion device comprising a fluid reservoir to contain a therapeutic fluid and a transcutaneous access tool fluidly coupled to the fluid reservoir, the transcutaneous access tool configured to deliver the therapeutic fluid subcutaneously to a patient; wherein the infusion device operates in a stand-by mode prior to the therapeutic fluid being introduced into the fluid reservoir; wherein the infusion device operates to deploy the transcutaneous access tool within a predetermined deployment time period upon filling the fluid reservoir to a predetermined fill level with the therapeutic fluid.

Claims (20)

1. A medical device comprising: an infusion device comprising a fluid reservoir to contain a therapeutic fluid and a transcutaneous access tool fluidly coupled to the fluid reservoir, the transcutaneous access tool configured to deliver the therapeutic fluid subcutaneously to a patient; wherein the infusion device operates in a stand-by mode prior to the therapeutic fluid being introduced into the fluid reservoir, and wherein, upon filling the fluid reservoir to a predetermined fill level with the therapeutic fluid when the infusion device is in stand-by mode, the infusion device generates a signal indicative that the fluid reservoir has been filled to the predetermined fill level with the therapeutic fluid,

wherein, upon generating the signal indicative that the fluid reservoir has been filled to the predetermined fill level with the therapeutic fluid, the infusion device uses the signal to cause automatic deployment of the transcutaneous tool once at least one processer detects the signal from at least one sensor that the fluid in the fluid reservoir has reached the predetermined fill level, and

wherein the automatic deployment of the transcutaneous tool occurs during a predetermined deployment time period, the predetermined deployment time period initiated by the occurrence of the filling of the fluid reservoir.

2. The medical device of claim 1 wherein: the predetermined deployment time period is greater than or equal to 30 seconds.

3. The medical device of claim 1 wherein: the predetermined deployment time period is less than or equal to 15 minutes.

4. The medical device of claim 1 wherein: the predetermined deployment time period is greater than or equal to 1 minute, and less than or equal to 10 minutes.

5. The method of claim 1 wherein: the predetermined deployment time period is greater than or equal to 2 minutes, and less than or equal to 5 minutes.

6. The medical device of claim 1 wherein: the infusion device comprises non-transitory memory including stored instructions for the predetermined deployment time period, that when executed by the at least one processor, cause an instruction to be sent from the non-transitory memory to deploy the transcutaneous access tool within the predetermined deployment time period.

7. The medical device of claim 6 wherein: the at least one sensor operates by sending the signal to the at least one processor when the therapeutic fluid in the fluid reservoir reaches the predetermined fill level.

8. The medical device of claim 7 wherein:

the at least one processor operates by detecting the signal from the at least one sensor; and

upon detecting the signal from the at least one sensor, the at least one processor operates to execute the instructions that cause the infusion device to deploy the transcutaneous access tool.

9. The medical device of claim 1 wherein: the infusion device operates to deliver the therapeutic fluid in the fluid reservoir through the transcutaneous access tool after a predetermined infusion delay time period.

10. The medical device of claim 9 wherein: the infusion device operates to initiate the predetermined infusion delay time period when the transcutaneous access tool is deployed.

11. The medical device of claim 10 wherein: the predetermined infusion delay time period is at least 1 hour.

12. The medical device of claim 10 , wherein: the predetermined infusion delay time period is at least 8 hours.

13. The medical device of claim 10 wherein: the predetermined infusion delay time period is at least 16 hours.

14. The medical device of claim 10 wherein: the predetermined infusion delay time period is at least 20 hours.

15. The medical device of claim 1 wherein: the transcutaneous access tool comprises a cannula.

16. The medical device of claim 1 wherein: the infusion device comprises an infusion pump.

Assignments (2)
SECURITY INTEREST Recorded May 4, 2021
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 056135/0974 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2016
From: SCHMID, KEVIN G.
To: INSULET CORPORATION
Reel/Frame 039304/0064 →
Cited By (23)
US 12,431,229 US 12,485,223 US 12,495,994 US 12,496,398 US 12,514,979 US 12,514,980 US 12,521,486 US 12,551,619 US 12,551,621 US 12,558,026 US 12,562,251 US 12,564,679 US 12,569,619 US 12,592,306 US 12,636,435 US 12,646,601 US 12,651,659 US 12,653,426 US 12,653,949 US 12,667,665 US 12,691,221 US 12,691,222 US 12,708,709